AON:NYSEAon plc Analysis
Data as of 2026-06-23 - not real-time
$320.74
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: Aon's shares are trading at $320.74, just below the 20‑day ($324.04) and 50‑day ($322.22) simple moving averages and well under the 200‑day SMA ($337.33), indicating short‑term weakness. The 14‑day RSI sits at 47, suggesting neutral momentum, while the MACD histogram is negative and the signal line is bearish, reinforcing a cautious short‑term bias. Volume is on an upward trend, providing liquidity for potential moves toward the identified support at $311.07 and resistance near $340.76.
Fundamental outlook: Aon delivers strong profitability with a 47.3% gross margin, 35.8% operating margin, and an impressive 46% ROE, supported by 6.5% revenue growth YoY. The balance sheet is leveraged (debt‑to‑equity ~155) but offset by robust operating cash flow ($3.77 B) and a modest dividend payout (16% of earnings) that appears sustainable. However, the DCF‑derived fair value of $204.40 is far below the current price, and analysts cite limited margin of safety, suggesting the stock may be overvalued despite a modest upside target of ~$382 from consensus estimates.
Fundamental outlook: Aon delivers strong profitability with a 47.3% gross margin, 35.8% operating margin, and an impressive 46% ROE, supported by 6.5% revenue growth YoY. The balance sheet is leveraged (debt‑to‑equity ~155) but offset by robust operating cash flow ($3.77 B) and a modest dividend payout (16% of earnings) that appears sustainable. However, the DCF‑derived fair value of $204.40 is far below the current price, and analysts cite limited margin of safety, suggesting the stock may be overvalued despite a modest upside target of ~$382 from consensus estimates.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term SMAs and bearish MACD
- Proximity to near‑term support at $311
- Increasing volume indicating potential volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong ROE and operating margins
- Forward EPS growth and lower forward P/E (~15x)
- Sustainable dividend yield with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Durable, recurring revenue model across risk, health, and wealth segments
- High profitability and cash generation supporting dividend stability
- Strategic positioning in a low‑growth, low‑volatility insurance brokerage sector
Key Metrics & Analysis
Financial Health
Revenue Growth6.50%
Profit Margin22.54%
P/E Ratio17.6
ROE46.45%
ROA6.05%
Debt/Equity155.05
P/B Ratio7.0
Op. Cash Flow$3.8B
Free Cash Flow$3.3B
Industry P/E17.0
Technical Analysis
TrendNeutral
RSI47.3
Support$311.07
Resistance$340.76
MA 20$324.04
MA 50$322.22
MA 200$337.33
MACDBearish
VolumeIncreasing
Fear & Greed Index86.63
Valuation
Fair Value$204.40
Target Price$382.37
Upside/Downside19.21%
GradeOvervalued
TypeValue
Dividend Yield1.05%
Risk Assessment
Beta-0.11
Volatility22.49%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.